The combination of the expression of hexokinase 2 and pyruvate kinase M2 is a prognostic marker in patients with pancreatic cancer

Hisataka Ogawa, Hideshi Ishii(Osaka University Hospital)
Molecular and Clinical Oncology
January 22, 2015
Cited by 63


Related Papers